Thanks John Fehilly for your school outreach activities during Science Week Ireland I'm sure they enjoyed the engaging presentation on your NUI Science Foundation Ireland research from UCD Conway Institute Ocular Pharmacology UCD SBBS Breandán Kennedy UCD

Congratulations to Elin Strachan, a UCD PhD student, on being named the winner of the 2023 SFI Research Image of the Year Award as part of today's #ResearchSummit in Cork. Congratulations to all this year's Awardees - sfi.ie/research-news/…

Fantastic news Elin Strachan Congrats from all the Ocular Pharmacology team and thanks to IrishResearch and Science Foundation Ireland for funding this research UCD Conway Institute UCD SBBS UCD Science

And it’s a wrap 👏🧬🔬#CuriosiTY programme #4 Science Foundation Ireland Systems Biology Ire - enjoyed hosting these young adults from St. Seton's Secondary School Collinstown Park CC Clogher Road Community College Drimnagh Castle CBS Hope to see you University College Dublin 🎓

An eye to scientific research developments in 2024 irishtimes.com/science/2023/1…

Dive into our Open Research Europe article to learn how cigarette smoke impacts visual behaviour, eye blood vessels, and retinas in zebrafish, hinting at potential effects on humans. 👁️🚬👇 open-research-europe.ec.europa.eu/articles/3-48 Marie Skłodowska-Curie Actions EUScience&Innovation🇪🇺 @cordis_eu #MSCA #H2020 #InvestEUResearch

🌍 Today is #WorldCancerDay Please join #FaceUpToCancer campaign supporting Breakthrough Cancer Research BreastCancerIreland Marie Keating Foundation raising funds for vital research. #DonateYourSelfie and make a difference together! 🎗️ #DonateNow #Cancer Ocular Pharmacology UCD Conway Institute #CancerResearch

1,4-dihydroxy quininib activates ferroptosis pathways in metastatic uveal melanoma (MUM) and reveals a novel prognostic biomarker signature for MUM. Our recent findings support ferroptosis as a potential clinical biomarker and therapeutic target for MUM. nature.com/articles/s4142…

Thanks to all the amazing collaborators (scientists, patients, advocates) who contributed to the realisation of this work. Breandán Kennedy UCD Ocular Pharmacology IrishResearch Breakthrough Cancer Research Xenopat CRYSTAL3 CONSORTIUM UCD Conway Institute Marie Skłodowska-Curie Actions [email protected] #UvealMelanoma #CancerResearch

Valentina Tonelotto Breandán Kennedy UCD Ocular Pharmacology IrishResearch Breakthrough Cancer Research Xenopat CRYSTAL3 CONSORTIUM UCD Conway Institute Marie Skłodowska-Curie Actions [email protected] Yes, thank you to everyone. You are amazing people and what you are doing for Uveal melanoma patients!

👁️ The 2024 Australasian Ocular Melanoma Alliance (AOMA) Virtual Summit program is now available! 5 International speakers 11 Australian #ocularmelanoma experts 4 Ocular melanoma consumers Sat 15 June - Registration is free! Watch from anywhere worldwide! masc.org.au/aoma-summit/

Best luck to all #CRSYTAL3 Researchers presenting at/going to #ARVO2024. Enjoy #Seatle !! 👁️🔬🥼🇺🇸 Ocular Pharmacology Ocupharm Research Group ARVO

"Two talks, twice the excitement! 🎉 Presented at both Irish Melanoma Forum and #SBBSRD24. I am honored to clinch the Best Talk at Irish Melanoma Forum! Huge thanks to everyone involved.Breakthrough Cancer Research Ocular Pharmacology IrishResearch Breandán Kennedy UCD UCD SBBS

A new approach to APCs | EMBO reports embopress.org/doi/full/10.10…

UCD students: which UCD faculty or staff have helped you during your studies? Nominate them for a UCD Teaching and Learning Award - closing date: 25 August ▶️ Nominate online now: ucd.ie/teaching/nomin…

1/4 | New Study Offers Hope Against Rare Eye Cancer Research shows 1,4-dihydroxy quininib might help in the fight against a deadly eye cancer. Learn more about the findings. goo.su/4AUZU #Health #CancerResearch #EUResearch #MSCA #PPI 👉 UCD Conway Institute Valentina Tonelotto

1/4 | Potential Treatment for Aggressive Eye Cancer Identified | UCD Conway Institute research highlights how 1,4-dihydroxy quininib may offer new options for treating metastatic uveal melanoma. goo.su/4AUZU #CancerResearch #OcularHealth  #EUResearch #MSCA

2/4 | From Lab to Clinic: What’s Next? | Valentina Tonelotto will discuss the journey from discovery to potential patient treatment as she wraps up her time at UCD Conway. goo.su/4AUZU #PPI #PatientVoice #CancerResearch #OcularHealth #ConwayInstitute #EUResearch #MSCA

3/4 | Keeping Patients at the Heart of Research | Our upcoming interview will explore how patient perspectives are shaping new cancer treatments at UCD Conway Institute. goo.su/4AUZU #PPI #PatientVoice #CancerResearch #OcularHealth #ConwayInstitute #EUResearch #MSCA

4/4 | Bringing New Cancer Treatments to Life | Learn about the challenges and opportunities in translating our recent discovery into real-world applications.  goo.su/4AUZU #PPI #PatientVoice #CancerResearch #OcularHealth #ConwayInstitute #EUResearch #MSCA